Novavax (NVAX) Announces $388M Funding from CEPI for COVID-19 Vaccine
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St futures decline as oil surge, high yields stoke inflation worries
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Goldman Sachs sees 18% upside for Palantir on sovereign AI growth
- Citi names 5 top chip picks ahead of Q3 earnings
- PepsiCo shares climb after Q3 beat, though company trims profit forecast
| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 11.22 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.22 | 52 Week High | $9.23 | |||
| Open | $11.22 | 52 Week Low | $1.16 | |||
| Day High | $11.22 | P/E | N/A | |||
| Day Low | $11.22 | EPS | $-0.30 | |||
| Volume | 24,407 | |||||
